NCT01086761 arm group b8ba4dfb268c42b20225e65652b2440f [clinicaltrials_resource:NCT01086761/arm-group/b8ba4dfb268c42b20225e65652b2440f]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01086761 arm group b8ba4dfb268c42b20225e65652b2440f [clinicaltrials_resource:NCT01086761/arm-group/b8ba4dfb268c42b20225e65652b2440f]
Bio2RDF identifier
NCT01086761/arm-group/b8ba4dfb268c42b20225e65652b2440f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... ba4dfb268c42b20225e65652b2440f
description [clinicaltrials_vocabulary:description]
Single 3.6 mg intravitreal injection of MP0112 in the study eye.
identifier
clinicaltrials_resource:NCT01086761/arm-group/b8ba4dfb268c42b20225e65652b2440f
title
NCT01086761 arm group b8ba4dfb268c42b20225e65652b2440f
@en
type
label
NCT01086761 arm group b8ba4dfb ...... a4dfb268c42b20225e65652b2440f]
@en